Zhou D, Dong X, Zhou Z, & Liu Q. (2023). Drug Pricing of Domestic Anti-PD-L1 Antibody Adebrelimab: Cost-Effectiveness Analysis of the First-Line ES-SCLC Treatment in China. Dove Medical Press.
Chicago Style (17th ed.) CitationZhou D, Dong X, Zhou Z, and Liu Q. Drug Pricing of Domestic Anti-PD-L1 Antibody Adebrelimab: Cost-Effectiveness Analysis of the First-Line ES-SCLC Treatment in China. Dove Medical Press, 2023.
MLA (9th ed.) CitationZhou D, et al. Drug Pricing of Domestic Anti-PD-L1 Antibody Adebrelimab: Cost-Effectiveness Analysis of the First-Line ES-SCLC Treatment in China. Dove Medical Press, 2023.
Warning: These citations may not always be 100% accurate.